Linter, Belgium

Geert Berx

This inventor holds 1 USPTO granted patent and 3 published patent applications. Top assignees: University of Ghent, Vlaams Interuniversitair Instituut Voor Biotechnologie Vzw. Active years: 2009.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Geert Berx. Retrieved from https://idiyas.com/inventor/geert-berx

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

Calculating rank
USPTO Granted Patents = 1 

Average Co-Inventor Count = 3.0

ph-index = 1


Company Filing History:


Years Active: 2009

Loading Chart...
1 patent (USPTO):Explore Patents

Title: Geert Berx: Innovator in Tumor Progression Control

Introduction

Geert Berx is a notable inventor based in Linter, Belgium. He has made significant contributions to the field of biotechnology, particularly in the area of cancer research. His innovative work focuses on methods to control tumor progression and invasiveness.

Latest Patents

Geert Berx holds a patent for a method to control tumor progression and invasiveness. This patent describes a method of modulating E-cadherin mediated cell adhesion. More specifically, it details the use of hECRep1a and homologues thereof to modulate and/or control tumor cell invasiveness. This groundbreaking approach has the potential to impact cancer treatment significantly.

Career Highlights

Throughout his career, Geert Berx has worked with esteemed organizations such as the Vlaams Interuniversitair Instituut Voor Biotechnologie and Universiteit Gent. His research and expertise have contributed to advancements in understanding tumor biology and developing therapeutic strategies.

Collaborations

Geert has collaborated with notable colleagues, including Frans Van Roy and Kristin Strumane. These partnerships have fostered a collaborative environment that enhances research outcomes and innovation.

Conclusion

Geert Berx is a distinguished inventor whose work in tumor progression control exemplifies the intersection of innovation and biotechnology. His contributions continue to pave the way for advancements in cancer treatment and research.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…